Literature DB >> 16083907

Guilty by association: some collagen II mutants alter the formation of ECM as a result of atypical interaction with fibronectin.

Hidetoshi Ito1, Eileen Rucker, Andrzej Steplewski, Erin McAdams, Raymond J Brittingham, Tatiana Alabyeva, Andrzej Fertala.   

Abstract

Among the structural components of extracellular matrices (ECM) fibrillar collagens play a critical role, and single amino acid substitutions in these proteins lead to pathological changes in tissues in which they are expressed. Employing a biologically relevant experimental model consisting of cells expressing R75C, R519C, R789C, and G853E procollagen II mutants, we found that the R789C mutation causing a decrease in the thermostability of collagen not only alters individual collagen molecules and collagen fibrils, but also has a negative impact on fibronectin. We propose that thermolabile collagen molecules are able to bind to fibronectin, thereby altering intracellular and extracellular processes in which fibronectin takes part, and we postulate that such an atypical interaction could change the architecture of the ECM of affected tissues in patients harboring mutations in genes encoding fibrillar collagens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16083907     DOI: 10.1016/j.jmb.2005.07.019

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  14 in total

1.  Collagen fibril formation. A new target to limit fibrosis.

Authors:  Hye Jin Chung; Andrzej Steplewski; Kee Yang Chung; Jouni Uitto; Andrzej Fertala
Journal:  J Biol Chem       Date:  2008-07-23       Impact factor: 5.157

2.  Exome sequencing reveals a novel COL2A1 mutation implicated in multiple epiphyseal dysplasia.

Authors:  Vinod Dasa; James R B Eastwood; Michal Podgorski; Heewon Park; Christopher Blackstock; Tetyana Antoshchenko; Piotr Rogala; Tadeusz Bieganski; S Michal Jazwinski; Malwina Czarny-Ratajczak
Journal:  Am J Med Genet A       Date:  2019-02-10       Impact factor: 2.802

3.  Matrix-specific anchors: a new concept for targeted delivery and retention of therapeutic cells.

Authors:  Andrzej Steplewski; Jolanta Fertala; Pedro Beredjiklian; Mark L Wang; Andrzej Fertala
Journal:  Tissue Eng Part A       Date:  2015-01-13       Impact factor: 3.845

Review 4.  Matrix metalloproteinase collagenolysis in health and disease.

Authors:  Sabrina Amar; Lyndsay Smith; Gregg B Fields
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-04-26       Impact factor: 4.739

5.  Consequences of Glycine Mutations in the Fibronectin-binding Sequence of Collagen.

Authors:  Panharith Chhum; Hongtao Yu; Bo An; Brian R Doyon; Yu-Shan Lin; Barbara Brodsky
Journal:  J Biol Chem       Date:  2016-10-31       Impact factor: 5.157

6.  Reducing the effects of intracellular accumulation of thermolabile collagen II mutants by increasing their thermostability in cell culture conditions.

Authors:  Katarzyna Gawron; Deborah A Jensen; Andrzej Steplewski; Andrzej Fertala
Journal:  Biochem Biophys Res Commun       Date:  2010-04-13       Impact factor: 3.575

7.  Persistence of intracellular and extracellular changes after incompletely suppressing expression of the R789C (p.R989C) and R992C (p.R1192C) collagen II mutants.

Authors:  Deborah A Jensen; Andrzej Steplewski; Katarzyna Gawron; Andrzej Fertala
Journal:  Hum Mutat       Date:  2011-05-05       Impact factor: 4.878

8.  Fluorescent protein markers to tag collagenous proteins: the paradigm of procollagen VII.

Authors:  Hye Jin Chung; Andrzej Steplewski; Jouni Uitto; Andrzej Fertala
Journal:  Biochem Biophys Res Commun       Date:  2009-10-12       Impact factor: 3.575

9.  R992C (p.R1192C) Substitution in collagen II alters the structure of mutant molecules and induces the unfolded protein response.

Authors:  Hye Jin Chung; Deborah A Jensen; Katarzyna Gawron; Andrzej Steplewski; Andrzej Fertala
Journal:  J Mol Biol       Date:  2009-05-08       Impact factor: 5.469

10.  Fibronectin molecular status determination useful to differentiate between rheumatoid arthritis and systemic lupus erythematosus patients.

Authors:  Magdalena Przybysz; Krzysztof Borysewicz; Iwona Kątnik-Prastowska
Journal:  Rheumatol Int       Date:  2012-01-04       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.